Lv13
20 积分 2024-01-10 加入
Deficient FANCL Predisposes Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension
1天前
已完结
Clinical Pharmacokinetics of Inhaled Drugs for Pulmonary Hypertension
3个月前
已完结
SGLT2 inhibitors as a potential therapeutic option for pulmonary hypertension: mechanisms and clinical perspectives
3个月前
已完结
Drugs targeting novel pathways in pulmonary arterial hypertension
3个月前
已完结
Drugs targeting novel pathways in pulmonary arterial hypertension
4个月前
已关闭
Mechanisms and treatment of pulmonary arterial hypertension
5个月前
已完结
Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation
7个月前
已完结
RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension
7个月前
已完结
The role of N6-methyladenosine in macrophage polarization: A novel treatment strategy for non-alcoholic steatohepatitis
7个月前
已完结
Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages
9个月前
已完结
皖公网安备34019202002308
